Atorvastatin Calcium Tablet
Product Images NDC 71335-2388

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71335-2388). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 01)

Chemical structure of atorvastatin calcium showing the molecular arrangement including the calcium ion (Ca2+) and associated water molecules (3H2O).*

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 02)

A line graph showing cumulative incidence (%) over 3.5 years comparing Atorvastatin and placebo groups. The solid line represents Atorvastatin, showing a lower cumulative incidence compared to the placebo dashed line. The graph includes a hazard ratio (HR) of 0.64 with confidence interval 0.50-0.83 and a p-value of 0.0005.*

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 03)

A line graph showing cumulative hazard percentage over time (up to 5 years) comparing Placebo and Atorvastatin treatment groups. The graph plots time to first primary endpoint through four years of follow-up, with Placebo showing higher cumulative hazard than Atorvastatin. Hazard ratio (HR) of 0.63 with confidence interval (0.48-0.83) and p-value 0.001 is displayed.*

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 04)

A line graph comparing time to first major cardiovascular event in years between subjects taking Atorvastatin 10 mg and 80 mg. The y-axis indicates the percentage of subjects experiencing the event, showing a slightly lower event rate for 80 mg over a 5-year period. Hazard ratio and p-value are noted on the graph.*

FDA Label Image

Label (Lbl713352388)

Atorvastatin Calcium Tablets USP 10 mg film-coated tablets in a package of 30 tablets. The label, repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Graviti Pharmaceuticals Pvt. Ltd., includes storage instructions, dosage strength, the NDC 71335-2388-1, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.